815 material Form 8-K filings that 659 companies we cover made with the SEC in March 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Acadia Pharmaceuticals appointed Jonathan M. Poole as a director on March 3, 2026, filling a board vacancy, and named him to the Audit Committee effective immediately. The filing details his director pay and an initial equity grant with a target value of $200,000, plus a prorated annual grant of $95,300, which adds to the board's composition and compensation terms but does not report any financial results.
Poole appointed to the Board on March 3, 2026 as a Class II director, with a term expiring at the 2027 Annual Meeting of Stockholders
Annual cash retainers of $50,000 for board service and $12,500 for Audit Committee membership, prorated per the Policy
Initial equity grant with target fair value of $200,000 and prorated annual grant with target fair value of $95,300, both vesting over one year to three years
Future annual equity grant target value of $400,000 starting with the 2026 Annual Meeting of Stockholders
On March 4, 2026, EPAM Systems entered into a $300 million accelerated share repurchase agreement with Morgan Stanley under its $1.0 billion buyback authorization approved in October 2025. EPAM received an initial delivery of 1,703,336 shares, worth $240 million at the March 4 closing price, with the final share count to be set by the average share price over the deal's term, less a discount. The company said it is funding the transaction with cash on hand and borrowings under its existing credit facility, and $452.5 million of authorization remains after the agreement.
Payment: $300 million to Morgan Stanley, signed March 4, 2026
Initial delivery: 1,703,336 shares, or $240 million at the March 4, 2026 closing price, expected by March 5, 2026
Final settlement expected no later than the second quarter of 2026; final share count depends on the volume-weighted average price, less a discount
Affiliates of LS Power, which received the shares as part of NRG's January 30, 2026 acquisition of LS Power portfolio entities, agreed to sell 14,300,000 NRG common shares at $164.00 each, for about $2.35 billion in gross proceeds to the sellers. NRG receives none of the offering proceeds, but it separately agreed to repurchase $300 million of its stock from the same sellers at the offering price, with that purchase closing alongside the offering on March 4, 2026. For shareholders, the filing shows a large block of previously issued shares entering the public market, partly offset by NRG's buyback under its existing repurchase program.
14,300,000 shares priced at $164.00 per share; sellers' gross proceeds about $2,345,200,000 before underwriting discounts; underwriters hold a 30-day option on 2,145,000 more shares.
NRG receives no proceeds; separate repurchase of 1,829,269 shares for about $300 million, closing March 4, 2026.
Lock-up on the remaining 8,120,731 shares runs 45 days from March 2, 2026; NRG waived the prior lock-up that ran to July 30, 2026.
Alnylam's Board granted CEO Yvonne Greenstreet a special performance share award effective March 2, 2026, with a target of 55,373 shares and a stated face value of $18.0 million. The award pays out only if the stock's future 30-day average price reaches thresholds starting at $500 and reaching $800 by December 31, 2029, so it creates no value unless shareholders see significant stock price gains.
Target award: 55,373 performance share units, face value $18.0 million based on the $325.07 closing price on the Grant Date
Vesting range: 50% to 200% of target, tied to future average stock price thresholds of $500, $600, $700 and $800
Baseline threshold of $500 must be met or the award is forfeited in full; vesting date is December 31, 2029
The award was granted concurrently with the March 2, 2026 annual equity grants to Greenstreet and other executives
Brown & Brown's Compensation Committee adopted a 2026 annual cash incentive plan for certain executive officers and approved performance-based stock awards on March 3, 2026. The awards tie executive pay to organic revenue growth, adjusted EBITDAC margin, five-year share price and earnings per share targets, which aligns payouts with long-term results shareholders would track.
Target 2026 cash incentives: J. Powell Brown $5,500,000; R. Andrew Watts $1,400,000; Chris L. Walker $1,400,000; J. Scott Penny $1,100,000
Performance stock awards granted March 3, 2026: J. Powell Brown $10,000,000; R. Andrew Watts $5,000,000; J. Scott Penny $2,500,000
Chris L. Walker received a performance stock unit grant valued at $1,500,000, with payouts measured over five years beginning January 1, 2026
WesBanco's board approved reducing its size from 19 directors to 15, effective at the conclusion of the 2026 Annual Meeting of shareholders in April 2026. Three directors accepted a voluntary retirement offer, and director Michael J. Crawford is retiring under the company's age policy. The board said the change was made to position it at an optimal size, since its current size is much larger than that of peers.
Board size falls from 19 to 15 directors, effective at the conclusion of the April 2026 Annual Meeting.
Abigail M. Feinknopf, James W. Cornelsen and D. Bruce Knox accepted the voluntary retirement offer, which includes a one-time restricted stock grant valued at $250,000.
Michael J. Crawford retires at the 2026 Annual Meeting under the policy requiring directors to be under 70 at election.
John L. Bookmyer and Joseph R. Robinson were reclassified to rebalance the board's three director classes, with Bookmyer nominated for a three-year term and Robinson for a one-year term.
On March 4, 2026, AbbVie completed an underwritten public offering of seven series of senior notes, totaling $8.0 billion in principal, maturing between 2028 and 2066. The notes are unsecured and rank equally with AbbVie's existing unsecured debt, so the offering adds to the company's long-term borrowing obligations that shareholders' interests sit behind.
Seven series issued: $750 million floating rate notes and $1.5 billion 3.775% notes due 2028 among the fixed-rate series, plus notes due 2031, 2033, 2036, 2056 and 2066 with coupons from 4.125% to 5.650%
Floating rate and 2028 notes mature March 3, 2028; the other series mature March 15 of their respective years
Notes governed by a Supplemental Indenture No. 12 dated March 4, 2026, with U.S. Bank Trust Company, National Association as trustee
Offering registered under a Form S-3ASR dated February 14, 2025; prospectus supplement dated February 24, 2026
SL Green appointed Chief Investment Officer Harrison Sitomer as its President on February 27, 2026, and he will keep the Chief Investment Officer role. The company also extended Chief Financial Officer Matthew DiLiberto's term through January 1, 2029, with a new employment agreement. Shareholders get a clearer management structure, and the filing sets out the pay terms for both executives.
Harrison Sitomer, 36, was appointed President on February 27, 2026, and has been Chief Investment Officer since 2022.
Sitomer's employment agreement runs from 1/1/26 to 1/1/30, with a base salary of $700,000 and a $750,000 signing bonus.
Sitomer's first time-based award is $3,300,000 in restricted stock, and his first performance-based LTIP award has a target value of $2,500,000.
DiLiberto's term as CFO is extended to January 1, 2029, with a base salary of $660,000 and a first time-based LTIP award of $1,540,000 made in February 2026.
Blueport Acquisition Ltd disclosed a consulting agreement, dated November 11, 2025, with Hurricane Corporate Services Ltd., a firm controlled by its Chief Financial Officer, Kulwant Sandher, to provide CFO services for a monthly fee of $3,000 plus reimbursable expenses. The filing also says the company orally agreed in November 2025 to pay each director $7,500 per quarter, a deal the company can end at any time. The related-party arrangement and director pay are disclosed for shareholders to weigh against the company's governance.
Consulting Agreement with Hurricane Corporate Services Ltd., controlled by CFO Kulwant Sandher, dated November 11, 2025
Monthly fee of $3,000 plus reimbursable expenses; term of three months, automatically renewed for three more months on February 11, 2026
Directors to receive $7,500 per quarter under an oral agreement that the company may terminate at any time
Walker & Dunlop and its operating subsidiary signed a seventeenth amendment to their warehousing credit agreement with PNC Bank on March 2, 2026. The amendment extends the facility's maturity to March 1, 2027, lowers the bulge commitment fee, and allows a temporary one-time advance of up to $2.5 billion through May 1, 2026.
Maturity of the warehousing agreement extended to March 1, 2027
Temporary one-time right to request an advance of up to $2.5 billion, available March 2, 2026 to May 1, 2026
Bulge Commitment Fee decreased; the company continues to guarantee the borrower's obligations
Stellar V Capital Corp. said its board elected Michael Braunstein as a class II director on February 28, 2026, filling the seat held by Harry Braunstein, who died on November 2, 2025. Michael Braunstein was also named to the Audit and Compensation Committees and as chair of the Nominating and Corporate Governance Committee, and the board determined he is independent under NASDAQ rules.
Michael Braunstein elected class II director on February 28, 2026, on recommendation of the Nominating and Governance Committee
Named to Audit Committee and Compensation Committee, and chair of Nominating and Corporate Governance Committee
Board determined he is independent under NASDAQ Stock Market listing rules
He is a partner at Braunstein Turkish LLP and managing member of Sunset Capital 1 LLC since November 2025
On February 26, 2026, Quanta Services' Compensation Committee adopted 2026 annual, long-term and discretionary incentive plans covering corporate employees, senior leadership and all employees, with specific target incentive amounts set for executive officers. The filing describes compensation structure rather than financial results, so it does not change reported performance.
Adopted February 26, 2026 by the Compensation Committee of the Board
2026 annual metrics include EBITDA, EBITDA margin and safety
Long-term metrics for January 1, 2026 to December 31, 2028 include return on invested capital, earnings per share and total stockholder return
MOZAYYX Acquisition Corp., a blank check company, closed its upsized initial public offering of 30,000,000 units at $10.00 per unit on February 26, 2026, generating $300 million in gross proceeds. The full $300 million was placed in a U.S.-based trust account, and the company completed a private sale of 3,610,000 warrants at $2.00 each for $7.22 million. The filing states the company has not selected a business combination target, so shareholders' funds stay in trust until a deal is completed or public shares are redeemed.
30,000,000 units sold at $10.00 each on February 26, 2026, including 3,900,000 units from the partial exercise of the underwriters' over-allotment option
$300,000,000 placed in a trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee
Private placement of 3,610,000 warrants at $2.00 each for $7,220,000; 2,305,000 sold to the sponsor and 1,305,000 to Cantor Fitzgerald & Co.
The company has not selected a business combination target and has 24 months from the IPO closing to complete one
M/I Homes director Norman L. Traeger, a board member since 1997, notified the company on February 27, 2026 that he will retire at the end of his current term and will not stand for re-election at the 2026 Annual Meeting of Shareholders. The company said it will name his successor in the proxy statement for that meeting, so shareholders will learn the replacement later.
Norman L. Traeger has served on the board since 1997 and gave notice on February 27, 2026.
He will not stand for re-election at the 2026 Annual Meeting of Shareholders.
The board's nominee to succeed him will be identified in the 2026 proxy statement.
The filing does not describe the reasons for the retirement.
Albemarle's board appointed Michelle T. Collins and Mark R. Widmar as independent directors, effective February 26, 2026, and the company announced the appointments on March 2, 2026. The filing describes the appointments as part of the board's regular succession planning and does not indicate any change in the company's financial results or operations.
Collins brings more than 40 years of audit and advisory experience, including a career at Deloitte & Touche LLP from 1996 until her retirement.
Widmar has served as Chief Executive Officer of First Solar since 2016 and previously held CFO roles at First Solar and GrafTech International.
Each director will receive an annual cash retainer of $120,000 and an annual restricted stock grant equal to $170,000 at the grant date, pro-rated for partial-year service.
Diamondback Energy and other selling stockholders sold 17,391,304 Class A shares of Viper Energy in a public offering priced at $45.90 per share, with closing expected March 4, 2026. Viper received no proceeds from the sale, but its operating subsidiary repurchased 1,000,000 units from Oaktree affiliates under the company's $1.75 billion repurchase program, which the board expanded to cover such purchases.
Offering price of $45.90 per share; gross proceeds to selling stockholders of approximately $798 million.
J.P. Morgan Securities and Goldman Sachs & Co. LLC acted as underwriters; underwriters hold an option for up to 2,608,696 additional shares.
OpCo repurchased 1,000,000 units from Oaktree affiliates, and a matching number of Class B shares were cancelled.
Approximately $1.23 billion remains available under the $1.75 billion share repurchase authorization, excluding excise tax.
Lithia Motors entered into a Seventh Amendment to its Fourth Amended and Restated Loan Agreement with U.S. Bank National Association as administrative agent, dated February 27, 2026. The amendment extends the credit facility's expiration date to February 27, 2031, and resets the financing commitment allocations across floorplan and revolving credit lines. For shareholders, the filing describes a longer-dated credit facility and changes to how financing is allocated, but it does not state any new borrowing amount or cost.
Credit facility expiration extended to February 27, 2031, with annual 1-year extension options subject to lender consent and other conditions
Upon election to convert to VIN-specific reporting, New Vehicle Floorplan $2.7 billion, Used Vehicle Floorplan $1.25 billion, Service Loaner Floorplan $150 million, Revolving Line of Credit $2.4 billion
H2O America priced an underwritten offering of 11,484,824 common shares at $53.00 per share on March 3, 2026, an increase of approximately $58.7 million over the offering size announced March 2. The company expects the net proceeds, together with certain debt financing, to fund its Quadvest acquisition, though the offering is not conditioned on that deal closing; new shares sold by the company or settled under forward sale agreements would dilute existing shareholders' earnings per share.
Priced at $53.00 per share for 11,484,824 shares; the company sells 3,937,654 shares directly and 7,547,170 shares are sold through forward sale agreements
Estimated net proceeds of approximately $588.9 million, or $677.2 million if the underwriters' option is exercised in full
Underwriters exercised their option in full on March 3, 2026, for 1,722,723 additional shares
Forward sale agreements have an initial forward price of $51.2775 per share and settle on or before March 2, 2028
Alignment Healthcare disclosed an underwritten offering in which a selling stockholder, not the company, sold 13,167,733 shares of common stock through J.P. Morgan Securities LLC. The offering closed on March 4, 2026, and the company said it will receive none of the proceeds, so the deal does not add new shares or cash to the company.
Underwriting agreement dated March 2, 2026, with J.P. Morgan Securities LLC and the selling stockholder
13,167,733 shares of common stock offered by the selling stockholder
Closing and delivery of shares took place March 4, 2026
Company will not receive any proceeds from the sale
Insulet Corporation entered into a severance agreement and release with Ana M. Chadwick, its former Chief Financial Officer, on February 27, 2026. The filing says the agreement implements severance benefits already disclosed in earlier filings and does not materially change those arrangements.
Agreement dated February 27, 2026, with former CFO Ana M. Chadwick
Terms do not differ materially from previously disclosed arrangements, per the Form 8-K filed September 16, 2025
Includes standard release of legal claims, mutual non-disparagement, and continuing confidentiality, non-solicit, non-compete, and IP assignment obligations
Filing dated March 4, 2026, signed by Patricia K. Dolan, Vice President and Secretary
BrightSpring Health Services agreed on March 2, 2026 to a secondary offering of 20,000,000 common shares at $41.15 per share, all sold by selling stockholders including KKR Phoenix Aggregator L.P. The offering closed March 4, 2026, and the company did not receive offering proceeds, but it repurchased 1,464,807 shares from the underwriter, which the filing says carried no underwriting fees.
Offering: 20,000,000 common shares sold by selling stockholders at $41.15 per share, led by Goldman Sachs & Co. LLC as underwriter
Company received no offering proceeds, apart from cash from management stock option exercises
Company repurchased 1,464,807 shares from the underwriter as part of the offering, with no underwriting fees
Offering was made under an automatic shelf registration filed June 10, 2025; closing occurred March 4, 2026
On March 4, 2026, Vir Biotechnology's board appointed Chief Executive Officer Marianne De Backer to the additional position of President. The filing describes no change to her compensation and no financial results, so the change is administrative in nature and reflects a broader role for the chief executive.
Marianne De Backer, Ph.D., remains Chief Executive Officer and principal executive officer and adds the title of President.
Board of Directors made the appointment on March 4, 2026.
Filing states no family relationship and no related-party transactions requiring disclosure for Dr. De Backer.
Biographical details are incorporated by reference from the proxy statement filed April 17, 2025.
Crane Harbor Acquisition Corp. II made available its PFIC Annual Statement for the period from June 19, 2025 to December 31, 2025, to holders of its Class A ordinary shares. The statement gives shareholders the per-unit, per-day ordinary earnings figure they may need to consider a Qualified Electing Fund election for U.S. federal tax purposes.
Tax period covered: June 19, 2025 to December 31, 2025
Reported ordinary earnings of 0.0010103085 US$ per unit per day; net capital gains listed as none
No cash or other property distributed to shareholders during the period
The QEF election is optional, must be made by each shareholder, and shareholders are advised to consult a tax advisor
Crown Holdings, Inc. announced that Michael P. Doss, former President and CEO of Graphic Packaging Corporation, joined its Board of Directors effective March 3, 2026, bringing the Board to ten members. The filing says he is expected to join the Audit Committee and will receive the same non-employee director compensation as other board members.
Michael P. Doss elected to Board effective March 3, 2026; Board now has ten members
Doss served as President, CEO and Director of Graphic Packaging Corporation from 2016 to 2025
Doss has been a Director of Regal Rexnord Corporation since 2023; expected to join the Audit Committee
XFLH Capital Corporation, a blank check company, said holders of its IPO units may separate the ordinary shares and rights starting March 9, 2026. The separated shares and rights will trade on the NYSE under XFLH and XFLHR, while unseparated units continue under XFLHU. This is an administrative trading change and does not report any financial results or a business combination.
Separate trading of ordinary shares (XFLH) and rights (XFLHR) begins March 9, 2026 on the NYSE.
Units not separated continue trading under XFLHU.
Each unit consists of one ordinary share and one right to receive one-seventh of a share upon the initial business combination.
Holders must have their brokers contact transfer agent Continental Stock Transfer & Trust Company to separate units.
Hexcel entered into a cooperation agreement with Vision One Fund, LP on March 3, 2026, under which the activist investor withdrew its nominees for the 2026 annual meeting and agreed to standstill, non-disparagement and voting commitments. The company appointed Neal J. Keating, former chairman, president and CEO of Kaman Corporation, to its Board and Audit Committee the same day.
Vision One Parties agreed to withdraw their nominees for the 2026 Annual Meeting and to customary standstill restrictions until the Expiration Date.
Neal J. Keating, age 70, was appointed to the Board and Audit Committee on March 3, 2026, and will be nominated for election at the 2026 annual meeting.
Board size is capped at ten directors until the 2026 Annual Meeting and nine directors afterward, subject to the Expiration Date terms in the agreement.
Celanese director Timothy Go resigned from the company's Board of Directors effective February 27, 2026, according to an 8-K filed March 4, 2026. The filing states the resignation was not due to any disagreement with the company on operations, policies, or practices.
Timothy Go resigned from the Board effective February 27, 2026
Filing states no disagreement with the company on operations, policies, or practices
Board and company thanked Mr. Go for his service as a Director
Effective March 3, 2026, the Fund extended the final mandatory redemption date for its Series 1 and Series 2 Variable Rate Demand Preferred Shares from September 11, 2026 to September 11, 2056. The filing is a Regulation FD disclosure and does not state the reason for the extension or any change to dividend terms.
Series 1 preferred shares with aggregate liquidation preference of $236.8 million now have a final mandatory redemption date of September 11, 2056.
Series 2 preferred shares with aggregate liquidation preference of $267.5 million now have the same extended date of September 11, 2056.
Dividends remain set weekly by a remarketing agent, subject to a maximum rate that can rise after extended unsuccessful remarketing.
FactSet said Kate Stepp, its former Chief Technology Officer, became Chief AI Officer, and Bob Stolte took over as Chief Technology Officer, both effective March 2, 2026. Stepp will lead the company's AI services for clients and report to CEO Sanoke Viswanathan, while Stolte will oversee the global technology organization, including cybersecurity and operational resilience.
Kate Stepp moves from Chief Technology Officer, a role she held since September 2022, to Chief AI Officer
Bob Stolte was appointed Chief Technology Officer, reporting to CEO Sanoke Viswanathan
Both appointments are effective March 2, 2026; the company announced them March 4, 2026
Dakota Gold Corp. said its publicly traded warrants, each exercisable for one common share at $2.08, will expire on March 15, 2026. The warrants will stop trading on the NYSE American under the symbol DC.WS on or about March 13, 2026, and the exchange intends to file a Form 25 to delist and deregister them. Common stock will keep trading as DC, so shareholders' common shares are not affected by the expiration.
Warrant expiration date: March 15, 2026
Exercise price: $2.08 per share, one common share per warrant
Warrants stop trading (DC.WS) on or about March 13, 2026, before market open
Common stock continues to trade on the NYSE American as DC
Ziff Davis said it signed a Securities Purchase Agreement on March 2, 2026, to sell its Connectivity division to Accenture Inc. for $1.2 billion in cash, subject to customary adjustments. The deal has been unanimously approved by the company's Board and is expected to close in the coming months, subject to closing conditions. Shareholders will see the company's remaining business change once the sale closes, though the filing does not state the financial effect of the sale.
Purchase price is $1.2 billion in cash, subject to customary adjustments set out in the agreement.
Agreement signed March 2, 2026, between Ziff Davis, Ziff Davis, LLC and Accenture Inc.
Deal can be terminated if it has not closed by December 2, 2026, which may be automatically extended to March 2, 2027.
At closing, Ziff Davis will provide transition services to Accenture under a Transition Services Agreement.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.